WiseGuyReports.com adds“Enteric Disease Testing and Therapeutic Market
Segmentation,Parameters and Prospects 2016 to 2022 Market Research Report”reports to its database.
COMPLETE
REPORT DETAILS @
https://www.wiseguyreports.com/reports/world-enteric-disease-testing-and-therapeutic-forecasts-2014-2022
Enteric diseases are the infections caused by ingestion of contaminated
food or water. These infections are commonly caused by bacteria and viruses.
Poor maintenance of hygiene and sanitation, particularly due to rising
population and urbanization is increasing the prevalence of enteric diseases.
According to World Health Organization (WHO), around 2.2 million people are
killed annually due to food and water-borne diarrheal diseases. There is an
impending global demand for better diagnostic and therapeutic options to
prevent the deaths from enteric diseases. The factors influencing the growth of
enteric disease testing and therapeutic market are higher incidence of infectious
diseases, overcrowded human population, poverty and lack of education about
health and safety standards, unavailability of safe drinking water in many
parts of the world and increasing microbial resistance to antibiotics.
Moreover, according to WHO estimate, unfavorable changes in world climatic
conditions such as rising global temperature and deforestation, would further
increase the incidence of infectious diseases. However, inaccessibility to
modern diagnostic and therapeutic options, high cost of equipment and lack of
expertise are likely to restrict the growth of the market.
For more information or any query mail at
sales@wiseguyreports.com
The global enteric disease testing and therapeutic market is segmented on
the basis of disease, diagnostics, therapeutics and geography. According to
disease, the market is segmented into bacterial disease such as typhoid,
cholera, shigellosis, salmonellosis, clostridium difficile infections and
campylobacteriosis; viral diseases such as rotavirus and novovirus infections;
and parasitic diseases such as amoebiasis and giardiasis. Diagnostics market is
segmented into diagnostic assays and rapid tests, testing of stool specimens,
Complete Blood Count (CBC) test, blood culture test, urine test, antibody test
and bone marrow test. Based on therapeutics, the global market is segmented
into vaccines, antibiotics, Oral Rehydration Therapy (ORT) and others such as vitamins
and zinc supplements. Geographically, the market is segmented across four
regions viz., North America, Europe, Asia-Pacific and LAMEA.
Few of the strategies adopted by the key industry players are new product
approval and acquisition. For instance, in May 2014, BD Diagnostics got FDA
approval for BD MAX Enteric Bacterial Panel, an in vitro diagnostic test
intended for the diagnosis of bacterial gastroenteritis. Similarly, Nanosphere
Inc., got FDA approval for Verigene Enteric Pathogens Nucleic Acid Test (EP), a
rapid diagnostic test for gastroenteritis. In July 2014, PaxVax acquired
marketing, sales and distribution rights of Vivotif, an oral typhoid vaccine
from Crucell Switzerland AG. The companies profiled in this report include
Alere, Inc., GlaxoSmithKline plc, Becton Dickinson and Company, bioMérieux SA,
Sanofi S.A., Bayer Pharma AG, Bio-Rad Laboratories, Inc., Quest Diagnostics
Inc., and Trinity Biotech plc.
KEY
MARKET BENEFITS:
Comprehensive analysis of factors that drive and restrict the growth of
the global enteric disease testing and therapeutic market is provided in the
report
The market estimations are made in the report by conducting high-end
analysis of the key market segments for the period of 2014-2020, which would
enable the stakeholders to capitalize on prevailing Market - Opportunities
An in-depth analysis of key segments of the market helps understand the
types of enteric diseases along with the diagnostics and therapeutics currently
being used in global enteric disease market
SWOT analysis enables to study the internal environment of the leading
companies for strategy formulation
Region-wise enteric disease testing and therapeutic market conditions are
comprehensively analysed in the report
REQUEST
FOR TABLE OF CONTENTS @ https://www.wiseguyreports.com/request-toc/world-enteric-disease-testing-and-therapeutic-forecasts-2014-2022
KEY
MARKET SEGMENTS:
The
global enteric disease testing and therapeutic market is segmented as below:
Global
Enteric Disease Testing and Therapeutic Market - By Disease
Bacterial disease
Typhoid
Cholera
Shigellosis
Salmonellosis
Clostridium difficile infections
Campylobacteriosis
Viral disease
Rotavirus infections
Novovirus infections
Parasitic diseases
Amoebiasis
Giardiasis
Global
Enteric Disease Testing and Therapeutic Market - By Diagnostics
Diagnostic assays and rapid tests
Testing of stool specimens
Complete Blood Count (CBC) test
Blood culture test
Urine test
Antibody test
Bone marrow test
Global
Enteric Disease Testing and Therapeutic Market - By Therapeutics
Vaccines
Antibiotics
Oral Rehydration Therapy (ORT)
Others
Vitamins and zinc supplements
Global
Enteric Disease Testing and Therapeutic Market - By Geography
North America
Europe
Asia-Pacific
LAMEA
RESEARCH
METHODOLOGY
With collective industry experience of about 200 years of its analysts
and experts, Allied Market Research (AMR) encompasses most infallible research
methodology for its market intelligence and industry analysis. We do not only
engrave the deepest levels of markets but also sneak through its slimmest
details for the purpose of our market estimates and forecasts. Our approach
helps in building greater market consensus view for size, shape and industry
trends within each industry segment. We carefully factor in industry trends and
real developments for identifying key growth factors and future course of the
market. Our research proceeds are the resultant of high quality data, expert
views and analysis and high value independent opinions. Our research process is
designed to deliver balanced view of the global markets and allow stakeholders
to make informed decisions.
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that
can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well
audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of
marketplace
CONTINUE…….
For more information or any query mail at sales@wiseguyreports.com
Contact
Us:
NORAH TRENT
Partner
Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph:
+44 208 133 9349 (UK)
No comments:
Post a Comment